8 Lung Cancer Clinical Trials in Long Beach, CA (2026)

Q: How do I join a clinical trial in Long Beach?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you.

Recruiting Lung Cancer Studies in Long Beach

NCT06623422Recruiting

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want ...

Long Beach, CAPHASE3680 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06875310Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo plus pembrolizumab plus platinum-doublet chemothera...

Long Beach, CAPHASE3630 participantsMirati Therapeutics Inc.

View Study Details

NCT04613596Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and ...

Long Beach, CAPHASE2626 participantsMirati Therapeutics Inc.

View Study Details

NCT06881784Recruiting

Study of Daraxonrasib (RMC-6236) in Previously Treated Patients With RAS Mutated NSCLC (RASolve 301)

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to docetaxel....

Long Beach, CAPHASE3590 participantsRevolution Medicines, Inc.

View Study Details

NCT05789082Recruiting

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of divarasib combined with other anti-cancer therapies in participants with previously untreated, advanced or m...

Long Beach, CAPHASE1320 participantsHoffmann-La Roche

View Study Details

NCT06095505Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer (SCLC) following progression on or after treatment with one platinum-...

Long Beach, CAPHASE2120 participantsPuma Biotechnology, Inc.

View Study Details

NCT06671613Recruiting

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment....

Long Beach, CANA66 participantsVA Office of Research and Development

View Study Details

NCT05467748Recruiting

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

This is an open label, single arm, phase Ib/II clinical trial of checkpoint blockade, pembrolizumab and EZH2 inhibitor, tulmimetostat combination therapy for patients with advanced non-small cell lung...

Long Beach, CAPHASE166 participantsVA Office of Research and Development

View Study Details

About Lung Cancer Clinical Trials in Long Beach

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 8 lung cancer clinical trials recruiting participants in Long Beach, CA. These studies are seeking a combined 3,098 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Mirati Therapeutics Inc., Revolution Medicines, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Long Beach — FAQ

Are there lung cancer clinical trials in Long Beach?

Yes, there are 8 lung cancer clinical trials currently recruiting in Long Beach, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Long Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.

Are clinical trials in Long Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 8 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 18, 2026 from ClinicalTrials.gov